Fujisawa Brand of Tacrolimus

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

76 API Suppliers, 30 USDMF, 11 CEP/COS, 7 JDMF, 9 EU WC, 12 KDMF, 24 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

497 FDF Dossiers, 63 FDA Orange Book, 206 Europe, 19 Canada, 96 Australia, 29 South Africa, 84 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 0.75MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 0.5MG BASE, CAPSULE;ORAL - EQ 1MG BASE, CAPSULE;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

2 SPI Pharma, 12 DKSH, 4 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Capital Farma, 4 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 3 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 38 Fillers, Diluents & Binders, 17 Controlled & Modified Release, 13 Granulation, 13 Lubricants & Glidants, 12 Direct Compression, 12 Thickeners and Stabilizers, 11 Film Formers & Plasticizers, 10 Disintegrants & Superdisintegrants, 9 Solubilizers, 9 Empty Capsules, 8 Topical, 7 Emulsifying Agents, 5 Taste Masking, 5 Coloring Agents, 5 Rheology Modifiers, 5 Co-Processed Excipients, 4 API Stability Enhancers, 4 Vegetarian Capsules, 3 Parenteral, 1 Surfactant & Foaming Agents, 1 Chewable & Orodispersible Aids